TrialPediatric blood & cancer2020

Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.

Javier E Oesterheld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.